How tirzepatide can affect your period

The fat-hormone link: why rapid weight loss reshapes your cycle

The most consistent explanation for menstrual changes on tirzepatide is the speed and scale of weight loss itself, not the medicine acting on the uterus or ovaries directly. Body fat is hormonally active: it stores and converts oestrogen, and when fat mass falls quickly, oestrogen levels can drop in tandem. A lower oestrogen signal can delay or shorten cycles, reduce flow, or (less commonly) cause a period to arrive earlier than usual.

The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average body-weight reductions of around 20% at the highest tirzepatide dose over 72 weeks, involving 2,539 adults. Weight loss at that pace creates hormonal conditions that gynaecologists recognise from other causes of rapid change — bariatric surgery, for example, produces the same pattern. The cycle typically stabilises once body weight plateaus and hormones recalibrate, which is broadly what women in tirzepatide programmes report over the first six to twelve months, and our page on what it means to have no period on Mounjaro explains the underlying reasons in more detail. More detail on how tirzepatide works in the body is covered on our tirzepatide overview page.

It is also worth knowing that calorie intake often falls sharply in early treatment as appetite is suppressed. Low energy availability alone can disrupt the hypothalamic-pituitary-ovarian axis, the hormonal feedback loop that runs the menstrual cycle. The two effects (weight loss and reduced intake) compound each other in the early weeks.

Tirzepatide, PCOS, and cycles that become more regular

For women with polycystic ovary syndrome, the picture is sometimes reversed: periods that were previously irregular may become more predictable. PCOS is driven partly by insulin resistance and elevated androgens. Tirzepatide's dual-receptor action (activating both GLP-1 and GIP pathways) improves insulin sensitivity, which reduces the androgen excess that suppresses ovulation in PCOS. When ovulation resumes, periods return. This can feel like a welcome development, but it carries a practical consequence: restored fertility where it had been reduced.

The NHS tirzepatide medicines page notes this possibility and advises women of childbearing age to use effective contraception throughout treatment and during the wash-out period before trying to conceive. Our page on whether tirzepatide affects your period covers this restoration effect in more depth.

If you had previously been told that conceiving naturally was unlikely due to PCOS, a returning cycle is a signal to review your contraception with your GP, not to assume the situation is unchanged. A prescriber at a service like ours would flag this at consultation, it is one reason clinical assessment matters before starting treatment.

Oral contraceptive pill absorption: what you need to know

Tirzepatide slows gastric emptying, the rate at which your stomach pushes food and medicines into the small intestine. For most oral medicines this matters little, but the combined oral contraceptive pill depends partly on consistent absorption timing. NHS England's guidance on weight-management injections advises that women on the oral pill add a barrier method (condoms, for example) for the first four weeks of tirzepatide treatment and for four weeks after each dose increase, as a precaution against reduced effectiveness.

The same guidance notes that no equivalent absorption concern has been identified for semaglutide (Wegovy). It also suggests discussing transdermal HRT (patches or gels rather than tablets) with your doctor if you are on hormone replacement therapy, for the same reason. Our page on Mounjaro and your period goes into the contraceptive question in more detail. If your current contraception method is not on the safe list, raise it with your prescriber before your first injection rather than after.

Cost is sometimes a factor in treatment decisions, and our Mounjaro price page sets out the market context plainly, including what a legitimate private price should include.

When to speak to a clinician, and what is probably fine to wait out

Most menstrual changes in the first two to three months of tirzepatide treatment are a normal physiological response to weight and hormonal change. A cycle that arrives a week early, a period that is lighter than usual, or one that takes longer to start than expected, these are common and generally resolve without intervention. Think of it like the period that sometimes goes haywire after a fortnight of holiday sickness: the body is reacting to a big internal shift.

Seek medical advice promptly rather than waiting if you experience: bleeding that is heavier than you have ever had before, spotting or bleeding between periods that persists beyond a couple of cycles, complete absence of periods for three or more months (amenorrhoea), or severe pelvic pain. Severe abdominal pain of any kind during tirzepatide treatment also warrants the same urgency, given the MHRA's January 2026 Drug Safety Update on acute pancreatitis as a known, if infrequent, risk with GLP-1 medicines. You can report unexpected side effects (or suspect sellers) through the MHRA's Yellow Card scheme.

You can read more about period-specific concerns, including pain changes, on our page about Mounjaro and period pain, or browse our wider weight-loss treatment information if you are still working out which route suits your situation. If you have specific questions, our clinical team (whose background you can read about on the clinical team page) reviews every consultation personally. When you are ready, start your free consultation and a GPhC-registered prescriber will assess your full picture.